University of Cambridge tarafından başlatılan, Avrupa Komisyonu 7. Çerçeve Programı ve NIH tarafından desteklenen, dünya üzerinde kalıtsal prostat kanserinde prostat kanseri riski oluşturabilecek genlerin tayini çalışması yapılmaktadır. Bu çalışmaya Eczacılık Fakültesi Farmasötik Toksikoloji Anabilim Dalı’nda öğretim üyesi Yrd. Doç. Dr. Nur Özten Kandaş ülkemizi temsil etmek üzere dahil olmuştur.
PRACTICAL Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome
Study | Acronym | Institution | Country |
Stockholm 1 | STHM1 | Karolinska Institutet | Sweden |
Stockholm 2 | STHM2 | Karolinska Institutet | Sweden |
Finnish Genetic Predisposition to Prostate Cancer Study | TAMPERE | University of Tampere | Finland |
TASPRAC Study | TASPRAC | University of Tasmania | Australia |
Prostate Cancer Study in Tata Memorial Centre, Navi Mumbai | TMC | Tata Memorial Centre, Navi Mumbai | India |
University of Toronto | Toronto | Princess Margaret Hospital, Toronto | Canada |
Practical study of Turkey | TuPractical | Bezmialem Vakif University | Turkey |
U.K. Genetic Prostate Cancer Study and The Prostate Cancer Research Foundation Study | UKGPCS | Institute of Cancer Research | UK |
Institut fuer Humangengetik Ulm | ULM | University of Ulm | Germany |
University of Southern California – Los Angeles Prostate Cancer Study | USC | University of Southern California | USA |
UTAH Study | UTAH | University of Utah | USA |
Prostate Cancer Study in Valais | Valais | Hopital Cantonal Universitaire de Geneve | Switzerland |
Wake Forest Baptist Medical Center | WFUBMC | Wake Forest University School of Medicine | China |
Washington University Genetics Study | WUGS | Washington University School of Medicine | USA |
Bilgi için : http://practical.ccge.medschl.cam.ac.uk/